Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Glioma 3Glioblastoma 3Central Nervous System Neoplasms 2Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Central Nervous System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Temozolomide 66Radiotherapy 34Carboplatin 22Carmustine 21Bevacizumab 21Irinotecan 18Filgrastim 18Surgical Procedures, Operative 14Vincristine 11Peripheral Blood Stem Cell Transplantation 11Etoposide 11Radiation 10O(6)-benzylguanine 10Magnetic Resonance Spectroscopy 9Lomustine 9Procarbazine 8Erlotinib Hydrochloride 8sargramostim 7IL13-PE38 7Everolimus 7Cyclophosphamide 7Chemotherapy, Adjuvant 7Thiotepa 6Radiotherapy, Intensity-Modulated 6Imatinib Mesylate 6Granulocyte Colony-Stimulating Factor 6Drug Therapy 6Cisplatin 6temsirolimus 5antineoplaston AS 2-1 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Astrocytoma × Craniotomy × Clear all
NCT01644955 2018-07-02

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
10 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡